Atossa Therapeutics

ATOSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$20.323 M

$2.36 -2.48%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$34.8M

Loss-making

Shares outstanding

9,979,298

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#395Neuphoria TherapeuticsNEUP$20.6M
#396Cellectar BiosciencesCLRB$20.5M
#397Atossa TherapeuticsATOS$20.3M
#398CelularityCELU$20.3M
#399Werewolf TherapeuticsHOWL$19.3M

Where these numbers come from

Share counts and financials for Atossa Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.